How would you manage a patient with MSS, KRAS mutated locally advanced rectal adenocarcinoma with a mixed response to neoadjuvant FOLFOX?
This involves the primary site responding but progression with new bone marrow involvement with resulting cytopenias.
Thank you for the response. Yes, a bone marrow bio...
In this patient with metastatic disease and change...
Thank you, Dr. @Mital S. Patel for your input. The...
Actually, you may expect to see improved cytopenia...